Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour

International Journal of Andrology

Volumn 34, Issue 4 PART 2, 2011, Pages

  Turnbull, C ^a   Rahman, N ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Epidemiology; Gene polymorphism; Genome studies; Testicular neoplasms; Testis

Indexed keywords

IMATINIB;

CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RISK; ETHNIC GROUP; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM CELL TUMOR; HEREDITY; HUMAN; MALE; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEMINOMA; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 79960860868     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01162.x     Document Type: Review

References (58)

1. Barbaro M, Balsamo A, Anderlid BM, Myhre AG, Gennari M, Nicoletti A, Pittalis MC, Oscarson M & Wedell A. (2009) Characterization of deletions at 9p affecting the candidate regions for sex reversal and deletion 9p syndrome by MLPA. Eur J Hum Genet 17, 1439-1447.
2. Boldajipour B & Raz E. (2007) What is left behind - quality control in germ cell migration. Sci STKE 2007, e16.
3. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R et al. (2006) Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 15, 443-451.
4. Dieckmann KP & Pichlmeier U. (1997) The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 80, 1954-1960.
5. Dong C & Hemminki K. (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2, 112, 616 nuclear families. Int J Cancer 92, 144-150.
6. Feldser DM, Hackett JA & Greider CW. (2003) Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 3, 623-627.
7. Ferlay J., Bray F, Pisani P & Parkin DM. (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. [IARC CancerBase No. 5. version 2.0], IARCPress, Lyon. IARC CancerBase No. 5.
8. Fernandez-Garcia I, Ortiz-de-Solorzano C & Montuenga LM. (2008) Telomeres and telomerase in lung cancer. J Thorac Oncol 3, 1085-1088.
9. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C et al. (2010) COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38, D652-D657.
10. Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, Chilvers CE & Pike MC. (1992) Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 65, 255-262.
11. Frolov A, Chahwan S, Ochs M, Arnoletti JP, Pan ZZ, Favorova O, Fletcher J, von Mehren M, Eisenberg B & Godwin AK. (2003) Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Mol Cancer Ther 2, 699-709.
12. Gajendran VK, Nguyen M & Ellison LM. (2005) Testicular cancer patterns in African-American men. Urology 66, 602-605.
13. Gori S, Porrozzi S, Roila F, Gatta G, De GU & Marangolo M. (2005) Germ cell tumours of the testis. Crit Rev Oncol Hematol 53, 141-164.
14. Hackett JA, Feldser DM & Greider CW. (2001) Telomere dysfunction increases mutation rate and genomic instability. Cell 106, 275-286.
15. Heaney JD, Lam MY, Michelson MV & Nadeau JH. (2008) Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Cancer Res 68, 5193-5197.
16. Hemminki K & Li X. (2004) Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 90, 1765-1770.
17. Hindorff LA, Junkins HA, Hall PN, Mehta JP & Manolio TA. A Catalog of Published Genome-Wide Association Studies. NHGRI, Accessed on 27 January 2011.
18. Holmes L Jr, Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ & Ward D. (2008) Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health 122, 862-872.
19. Holzik MF, Rapley EA, Hoekstra HJ, Sleijfer DT, Nolte IM & Sijmons RH. (2004) Genetic predisposition to testicular germ-cell tumours. Lancet Oncol 5, 363-371.
20. Horwich A, Shipley J & Huddart R. (2006) Testicular germ-cell cancer. Lancet 367, 754-765.
21. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R et al. (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41, 811-815.
22. Kang JU, Koo SH, Kwon KC, Park JW & Kim JM. (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182, 1-11.
23. Kolonel LN, Altshuler D & Henderson BE. (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4, 519-527.
24. Krentz AD, Murphy MW, Kim S, Cook MS, Capel B, Zhu R et al. (2009) The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci USA 106, 22323-22358.
25. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85, 679-691.
26. Liu L, Ishihara K, Ichimura T, Fujita N, Hino S, Tomita S, Watanabe S, Saitoh N, Ito T & Nakao M. (2009) MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. J Biol Chem 284, 5165-5174.
27. Livadas S, Mavrou A, Sofocleous C, van Vliet-Constantinidou C, Dracopoulou M & cou-Voutetakis C. (2003) Gonadoblastoma in a patient with del(9)(p22) and sex reversal: report of a case and review of the literature. Cancer Genet Cytogenet 143, 174-177.
28. Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA et al. (2009) The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol 28, 492-499.
29. Manolio TA. (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363, 166-176.
30. McGlynn KA, Devesa SS, Graubard BI & Castle PE. (2005) Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 23, 5757-5761.
31. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40, 1404-1406.
32. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet 31, 55-59.
33. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K et al. (2005) The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 77, 1034-1043.
34. Pedersini R, Vattemi E, Mazzoleni G & Graiff C. (2007) Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT. Lancet Oncol 8, 1039-1040.
35. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42, 224-228.
36. Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, Rubertone MV, Erickson RL & McGlynn KA. (2007) A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 16, 77-83.
37. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41, 221-227.
38. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39, 165-167.
39. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA et al. (2009) A genome-wide association study of testicular germ cell tumor. Nat Genet 41, 807-810.
40. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38, 873-875.
41. Roskoski R Jr. (2005) Signaling by Kit protein-tyrosine kinase - the stem cell factor receptor. Biochem Biophys Res Commun 337, 1-13.
42. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M, Kuriyama M, Saito N, Shibuya M & Yoshimura A. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Cell Cycle 2, 281-282.
43. Schrader M, Burger AM, Muller M, Krause H, Straub B, Schostak M, Schulze W, Lauke H & Miller K. (2002a) The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase. BMC Cancer 2, 32.
44. Schrader M, Burger AM, Muller M, Krause H, Straub B, Smith GL, Newlands ES & Miller K. (2002b) Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR. Oncol Rep 9, 1097-1105.
45. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38, 1239-1241.
46. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41, 899-904.
47. Skakkebaek NE. (1972) Possible carcinoma-in-situ of the testis. Lancet 2, 516-517.
48. Smith CA, McClive PJ, Western PS, Reed KJ & Sinclair AH. (1999) Conservation of a sex-determining gene. Nature 402, 601-602.
49. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41, 909-914.
50. Starr JR, Chen C, Doody DR, Hsu L, Ricks S, Weiss NS & Schwartz SM. (2005) Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiol Biomarkers Prev 14, 2183-2190.
51. Swerdlow AJ, De Stavola BL, Swanwick MA & Maconochie NE. (1997) Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 350, 1723-1728.
52. The International HapMap Consortium (2003) The International HapMap Project. Nature 426, 789-796.
53. The International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861.
54. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 42, 604-607.
55. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40, 1407-1409.
56. Yamamoto K, Okamoto A, Isonishi S, Ochiai K & Ohtake Y. (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 280, 1148-1154.
57. Yan W, Samson M, Jegou B & Toppari J. (2000) Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol 14, 682-699.
58. Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A & Wallin KL. (2002) Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 101, 427-433.